Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
Ornello R, Baraldi C, Guerzoni S, Lambru G, Andreou AP, Raffaelli B, Gendolla A, Barbanti P, Aurilia C, Egeo G, Cevoli S, Favoni V, Vernieri F, Altamura C, Russo A, Silvestro M, Valle ED, Mancioli A, Ranieri A, Alfieri G, Latysheva N, Filatova E, Talbot J, Cheng S, Holle D, Scheffler A, Nežádal T, Čtrnáctá D, Šípková J, Matoušová Z, Casalena A, Maddestra M, Viola S, Affaitati G, Giamberardino MA, Pistoia F, Reuter U, Sacco S. Ornello R, et al. Among authors: talbot j. J Headache Pain. 2022 Mar 19;23(1):38. doi: 10.1186/s10194-022-01408-w. J Headache Pain. 2022. PMID: 35305579 Free PMC article.
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men.
Ornello R, Baraldi C, Guerzoni S, Lambru G, Fuccaro M, Raffaelli B, Gendolla A, Barbanti P, Aurilia C, Cevoli S, Favoni V, Vernieri F, Altamura C, Russo A, Silvestro M, Dalla Valle E, Mancioli A, Ranieri A, Alfieri G, Latysheva N, Filatova E, Talbot J, Cheng S, Holle D, Scheffler A, Nežádal T, Čtrnáctá D, Šípková J, Matoušová Z, Sette L, Casalena A, Maddestra M, Viola S, Affaitati G, Giamberardino MA, Pistoia F, Reuter U, Sacco S. Ornello R, et al. Among authors: talbot j. Front Neurol. 2021 Dec 16;12:774341. doi: 10.3389/fneur.2021.774341. eCollection 2021. Front Neurol. 2021. PMID: 34975732 Free PMC article.
The safety and tolerability of sumatriptan: an overview.
Brown EG, Endersby CA, Smith RN, Talbot JC. Brown EG, et al. Among authors: talbot jc. Eur Neurol. 1991;31(5):339-44. doi: 10.1159/000116762. Eur Neurol. 1991. PMID: 1653142 Clinical Trial.
Pathology of idiopathic megarectum and megacolon.
Gattuso JM, Kamm MA, Talbot JC. Gattuso JM, et al. Among authors: talbot jc. Gut. 1997 Aug;41(2):252-7. doi: 10.1136/gut.41.2.252. Gut. 1997. PMID: 9301507 Free PMC article.
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial.
Slevin F, Alexander S, Brown SR, Carter M, Choudhury A, Clipson A, Din O, Dive C, Gilbert A, Girvan S, Hingorani M, Jain S, Khoo V, Lilley J, Murray LJ, Naismith O, Noutch S, Oliveira P, Pagett CJH, Smith A, Talbot J, Webster J, Henry AM. Slevin F, et al. Among authors: talbot j. BMJ Open. 2024 Dec 26;14(12):e095560. doi: 10.1136/bmjopen-2024-095560. BMJ Open. 2024. PMID: 39725427 Free PMC article.
968 results